|Bid||115.00 x 800|
|Ask||136.00 x 1000|
|Day's Range||123.13 - 123.13|
|52 Week Range||59.08 - 140.91|
|Beta (3Y Monthly)||1.56|
|PE Ratio (TTM)||34.68|
|Earnings Date||May 6, 2019 - May 10, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||133.80|
Amedisys Inc NASDAQ/NGS:AMEDView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for AMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold AMED had net inflows of $3.52 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
It might be of some concern to shareholders to see the Amedisys, Inc. (NASDAQ:AMED) share price down 11% in the last month. But over five years returns have been remarkablyRead More...
Zacks.com featured expert Kevin Matras highlights: Robert Half International, Caseys General Stores, Amedisys, Foot Locker and Comfort Systems USA
BATON ROUGE, La., March 05, 2019 -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that Paul B..
Amedisys Inc is a provider of home health services to the chronic, co-morbid, aging American population. Warning! GuruFocus has detected 2 Warning Sign with AMED. For the last quarter Amedisys Inc reported a revenue of $434.4 million, compared with the revenue of $404.2 million during the same period a year ago.
Today we'll look at Amedisys, Inc. (NASDAQ:AMED) and reflect on its potential as an investment. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us anRead More...
BATON ROUGE, La., Feb. 27, 2019 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2018. Three Month.
Paul B. Kusserow, President and Chief Executive Officer, stated, “While accretive acquisitions remain our first priority for capital deployment, we believe that opportunistic share repurchases should always be a consideration as part of a diversified capital allocation strategy. Under the stock repurchase program, the Company may repurchase its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions and other considerations and in accordance with applicable federal securities laws and other legal requirements.
Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.
Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean
If a company is highly leveraged, investors will not add it to their portfolios. A high degree of financial leverage means high interest payments, which may affect a company's bottom line.
NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys, Inc. (AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire RoseRock Healthcare, a hospice care provider in Tulsa, Oklahoma. Under the terms of the agreement, expected to close on April 1, 2019, Amedisys will acquire substantially all the assets of RoseRock Healthcare. RoseRock provides specialized hospice care to approximately 200 patients daily in northeastern Oklahoma.